Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
12/05/1996 | WO1996038467A1 Fragile x related proteins, compositions and methods of making and using the same |
12/05/1996 | WO1996038463A1 Dna sequence and encoded mammary-specific breast cancer protein |
12/05/1996 | WO1996038178A1 Allogeneic and xenogeneic transplantation |
12/05/1996 | WO1996038171A1 Methods of raising antibodies against e.coli of the family cs4-cfa/1 |
12/05/1996 | WO1996038164A1 Serum immunoregulatory polypeptides and uses therefor |
12/05/1996 | WO1996034099A3 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
12/05/1996 | DE19513595C1 Antikörper gegen Herzmuskel-Actin Antibodies against heart muscle actin |
12/05/1996 | CA2741641A1 Antibody specific for a mammaglobin polypeptide |
12/05/1996 | CA2222968A1 Diagnosis of, and vaccination against, a positive stranded rna virus using an isolated, unprocessed polypeptide |
12/05/1996 | CA2222863A1 Serum immunoregulatory polypeptides and uses therefor |
12/05/1996 | CA2222752A1 Human ice homolog |
12/05/1996 | CA2222419A1 A novel form of dipeptidylpeptidase iv (cd26) found in human serum, antibodies thereto, and uses therefor |
12/05/1996 | CA2220955A1 A novel human purinergic p2u receptor |
12/05/1996 | CA2217131A1 Modified cells and methods for inhibiting xenograft rejection |
12/04/1996 | EP0745852A1 Use of functional derivatives of the intercellular adhesion molecule ICAM-1 in anti-viral therapy |
12/04/1996 | EP0745668A2 DNA coding for sulfotransferase |
12/04/1996 | EP0745612A1 Anti-idiotypic antibodies which induce an immune response against epidermal growth factor receptor |
12/04/1996 | EP0745611A1 Interleukin-4 and Interleukin-1beta synergistically induce VCAM-1 |
12/04/1996 | EP0745602A1 Quinidine immunoassay and reagents |
12/04/1996 | EP0745136A1 B7-1-specific ligands, and their use for the induction of t cell anergy |
12/04/1996 | EP0745129A1 Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use |
12/04/1996 | EP0745128A1 Hepatitis b virus mutants, reagents and methods for detection |
12/04/1996 | EP0745125A1 Hematopoietic protein and materials and methods for making it |
12/04/1996 | EP0745124A1 Mammalian cell cycle protein |
12/04/1996 | EP0744958A1 Polyclonal antibody libraries |
12/04/1996 | EP0744957A1 Composition and method for preventing and treating inflammation with immunoglobulin a |
12/04/1996 | EP0744956A1 Peptides and methods against diabetes |
12/04/1996 | EP0479920B1 Novel antibodies reactive with human carcinomas |
12/03/1996 | US5581002 Blocking with butyldimethylsilanyl chloride; alkylation; ozonolyzing with sodium hypochlorite; deblocking |
12/03/1996 | US5580968 Useful in diagnosing and following the course of rheumatoid arthitis |
12/03/1996 | US5580962 Purification of activated protein c by ion exchange chromatography to remove serum amyloid p, antibodies and thrombin-inhibitor complex, then inactivating viruses |
12/03/1996 | US5580960 KS-laminin and methods of use |
12/03/1996 | US5580780 Vascular adhesion protein-(VAP-1) and VAP-1-specific antibodies |
12/03/1996 | US5580774 Anticarcinogenic agents |
12/03/1996 | US5580771 Phosphodiesterases catalyze hydrolysis of cyclic nucleotides, and control cellular concentration of cyclic nucleotides |
12/03/1996 | US5580769 Antiviral protein secreted by peripheral blood lymphocytes which inhibits replication of retroviruses including human immunodeficiency virus |
12/03/1996 | US5580756 Ligand which is reactive with the cd28 receptor on t cells |
12/03/1996 | US5580755 Human pluripotent granulocyte colony-stimulating factor |
12/03/1996 | US5580754 Culturing; transformation; transfection; isolation |
12/03/1996 | US5580753 DNA encoding the human cytokine, interleukin-9 |
12/03/1996 | US5580748 Measuring the presence or absence of a particular potassium channel; assessing the effect of poassium channel blockers on intracellular calcium levels; and, measuring activated intracellular calcium release |
12/03/1996 | US5580740 Antihuman pulmonary adenocarcinoma monoclonal antibody |
12/03/1996 | US5580738 Delta-like gene expressed in neuroendocrine tumors |
12/03/1996 | US5580736 Having a cell with a reporter gene linked to a dna sequence comprising a protein binding site, a first and second fusiongene; interacting the binding proteins expressed; measuringthe expression of the reporter gene |
12/03/1996 | US5580723 Comparing the activities of a segment-substituted polypeptide and the parent polypeptide; borrowing receptor binding properties from functionally divergent hormones |
12/03/1996 | US5580717 Recombinant library screening methods |
12/03/1996 | US5580561 Methods and pharmaceutical compositions for blocking suppression of immune defense mechanisms using an antibody, a factor, or an antisense peptide |
12/03/1996 | CA1338771C Adhesion receptor for laminin and its use |
12/03/1996 | CA1338770C Vinyl substituted radiohalogen conjugates for protein labeling |
12/01/1996 | CA2176417A1 Quinidine immunoassay and reagents |
11/28/1996 | WO1996037782A1 Method for potentiating tissue plasminogen activators |
11/28/1996 | WO1996037780A1 Compositions and methods for detecting schizophrenia |
11/28/1996 | WO1996037621A2 Multimeric proteins |
11/28/1996 | WO1996037611A1 Eb1 gene product binds to apc |
11/28/1996 | WO1996037606A1 Compositions and methods for the diagnosis of, and vaccination against, hepatitis c virus (hcv) |
11/28/1996 | WO1996037602A1 Porcine hepatocytes for use in treatment of disorders characterized by insufficient liver function |
11/28/1996 | WO1996037516A1 Methods of treatment and diagnostic visualisation, particularly in cancer |
11/28/1996 | WO1996037508A1 Protegrins |
11/28/1996 | WO1996037234A1 Intracellular immunization |
11/28/1996 | WO1996037225A1 Method for treatment of sle |
11/28/1996 | WO1996037224A1 Methods of treating colon cancer utilizing tumor-specific antibodies |
11/28/1996 | WO1996037221A1 Subunit vaccine against flavivirus infection |
11/28/1996 | WO1996037218A1 Parasitic helminth venom allergen antigen 5-like genes and proteins |
11/28/1996 | WO1996037211A1 Latent transcripts and promoters of cytomegalovirus |
11/28/1996 | WO1996029413A3 Dna encoding human papilloma virus type 18 |
11/28/1996 | WO1996021734A3 P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods |
11/28/1996 | CA2222475A1 Protegrins |
11/28/1996 | CA2222055A1 Multimeric proteins |
11/28/1996 | CA2221935A1 Method of treating colon cancer utilizing tumor-specific antibodies |
11/28/1996 | CA2221818A1 Parasitic helminth venom allergen antigen 5-like genes and proteins |
11/28/1996 | CA2221383A1 Method for potentiating tissue plasminogen activators |
11/28/1996 | CA2221159A1 Eb1 gene product binds to apc |
11/28/1996 | CA2220415A1 Latent transcripts and promoters of cytomegalovirus |
11/28/1996 | CA2220007A1 Porcine hepatocytes for use in treatment of disorders characterized by insufficient liver function |
11/28/1996 | CA2219479A1 Methods of treatment and diagnostic visualisation, particularly in cancer |
11/27/1996 | EP0743983A1 Mammalian thymokine genes |
11/27/1996 | EP0743958A1 Non-viral vector |
11/27/1996 | EP0743956A1 Pretargeting methods and compounds |
11/27/1996 | EP0743870A1 Preparation and application of artificial anti-idiotypic imprints |
11/27/1996 | EP0743856A1 Antigen-based heteropolymers and method for treating autoimmune diseases using the same |
11/27/1996 | EP0495878B1 Method for purifying chelator conjugated compounds |
11/27/1996 | EP0491867B1 Hybridoma ct43 producing a monoclonal antibody to a mucin epitope of colorectal cancer |
11/27/1996 | EP0446361B1 Polypeptide, production thereof, and pharmaceutical composition and cosmetic containing said polypeptide |
11/27/1996 | CN1136778A Sperm antigen corresponding to sperm zone binding protein autoantigenic epitope |
11/27/1996 | CA2177328A1 Anti-idiotypic antibodies which induce an immune response against epidermal growth factor receptor |
11/26/1996 | US5579250 Computer-assisted method |
11/26/1996 | US5578714 DNA encoding Duffy 9pd protein |
11/26/1996 | US5578708 Derived from bones of mammals including mice and humans; diagnosis and therapy for bone metabolic diseases |
11/26/1996 | US5578707 Soluble interferon-gamma receptor fragment |
11/26/1996 | US5578706 Methods and compositions concerning homogenous immunotoxin preparations |
11/26/1996 | US5578704 Bone disorders |
11/26/1996 | US5578703 Dimer proteins which bind to transforming growth factor |
11/26/1996 | US5578569 Method of increasing bone growth |
11/26/1996 | US5578500 Reagents and methods for the quantification of imipramine or desipramine in biological fluids |
11/26/1996 | US5578484 For detection of prostate cancer |
11/26/1996 | US5578482 Ligand growth factors that bind to the erbB-2 receptor protein and induce cellular responses |
11/26/1996 | US5578453 Cloning and expression of toxoplasma antigens and use of recombinant antigens |
11/26/1996 | US5578448 Polymerase chain reaction |
11/26/1996 | US5578323 Proteinoid carriers and methods for preparation and use thereof |
11/26/1996 | US5578309 For the treatment of candidiasis |